Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.

CONCLUSIONS: Potassium canrenoate at high doses can be used safely in association with standard diuretics in acute heart failure, even in patients with altered renal function. A prospective study is required to evaluate the efficacy of high-dose potassium canrenoate in preventing hypokalaemia and improving decongestion. PMID: 32948466 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32948466?dopt=Abstract

Source: Archives of Cardiovascular Diseases - September 14, 2020 Category: Cardiology Authors: Berger C, Prieur C, Bochaton T, Berthiller J, Luyt CE, Bonnefoy-Cudraz E Tags: Arch Cardiovasc Dis Source Type: research